Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00376558 · ClinicalTrials.gov registry record · NA
Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00376558 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 50 participants.
The verdict
NCT00376558, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patients with the greatest loss of dopamine transmission due to cocaine dependence at pre-treatment PET and MRI scans will be those who fail to respond to substance abuse treatment. This study will also determine whether patients who do respond to treatment will experience a recovery of dopamine function. This study includes free brain imaging and behavioral intervention. Compensation provided for the brain scans.
Interventions
- BEHAVIORAL Community Reinforcement Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-07 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00376558
The ClinicalTrials.gov registry entry for NCT00376558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Community Reinforcement Approach is the first listed.
NCT00376558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00376558 about?
NCT00376558 is a clinical study titled "Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence". The purpose of this study is to determine whether patients with the greatest loss of dopamine transmission due to cocaine dependence at pre-treatment PET and MRI scans will be those who fail to respond to substance abuse treatment. This study will also determine whether patients who do respond to tr...
What is the current status of trial NCT00376558?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2006-07. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00376558?
The interventions under investigation include: Community Reinforcement Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT00376558?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.